- A new iPhone app launched by Apple today will provide physician researchers with instant data from breast cancer survivors with a goal of providing patients improved post-treatment quality of life.
Tags: BreastCancer, Survivorship
- Dana-Farber is one of 379 employers and employer organizations that signed on to an amicus curiae brief filed by Morgan Lewis in the United States Supreme Court in support of a single uniform law for same sex marriage.
- Websites that market personalized cancer care services often overemphasize their purported benefits and downplay their limitations, and many sites offer genetic tests whose value for guiding cancer treatment has not been shown to be clinically useful, according to a new study from Dana-Farber Cancer Institute.
Tags: Genomics, Genetics
- With March marking Colorectal Cancer Awareness Month, Dr. Jeffrey Meyerhardt answers some key questions about the disease.
- A new laboratory test predicts which of several cancer drugs will work best against a patient's tumor, and could become a powerful precision medicine tool for individualizing cancer therapy.
- New patients with cancer can now make an appointment to see an oncologist as soon as the following day at Dana-Farber/Brigham and Women's Cancer Center.
- A study by Dana-Farber Cancer Institute scientists indicates that the pool of patients who can benefit from the drug olaparib is potentially much wider — and offers a ready means of identifying them.
Tags: BreastCancer, OvarianCancer
- The Commission on Cancer has recognized the Dana-Farber/Brigham and Women's Cancer Center for its dedication to providing quality care to its patients and accorded it a three year accreditation.
- Scientists publish the first comprehensive catalog of genetic mutations and other abnormal changes found in 279 cancers of the head and neck, identifying several broken molecular pathways that might be targeted by existing and future cancer drugs.
Tags: BasicResearch, Genomics, HeadNeckCancers
Showing 11-20 of 584 items